TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) Investor Investigation Concerning Potential Violations of Securities Laws

  • If you purchased shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

May 19, 2015 (Update) - On May 4, 2015, a news reports stated that AcelRx Pharmaceuticals Inc said a division of the FDA had rejected the company's request for a meeting to discuss the need for an additional trial of its pain drug device, Zalvizo. Shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) declined on May 13, 2015 to as low as $2.96 per share. March 16, 2015, (Update) - On Mar...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)